MetLife Investment Advisors »

Myriad Genetics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $817k 43k 19.14
2023-09-30 $684k 43k 16.04
2023-06-30 $989k 43k 23.18
2023-03-31 $991k 43k 23.23
2022-12-31 $619k 43k 14.51
2022-09-30 $814k 43k 19.08
2022-06-30 $775k 43k 18.17
2022-03-31 $1.1M 43k 25.20
2021-12-31 $757k 27k 27.60
2021-09-30 $885k 27k 32.29
2021-06-30 $838k 27k 30.58
2021-03-31 $835k 27k 30.45
2020-12-31 $629k 32k 19.77
2020-09-30 $415k 32k 13.04
2020-06-30 $361k 32k 11.35
2020-03-31 $455k 32k 14.31
2019-12-31 $866k 32k 27.23
2019-09-30 $911k 32k 28.63
2019-06-30 $827k 30k 27.79
2019-03-31 $988k 30k 33.20
2018-12-31 $865k 30k 29.07
2018-09-30 $2.1M 46k 46.00
2018-06-30 $1.1M 30k 37.36
2018-03-31 $879k 30k 29.53
2017-12-31 $1.0M 30k 34.34